A Breath of Fresh Air for Young Skin: FDA Expands Opzelura's Approval to Treat Pediatric Atopic Dermatitis
Breakthrough Hope: AbbVie's Next-Gen Alopecia Drug Shows Staggering Results in Late-Stage Trial